Atypical antipsychotic drugs: Beyond acute psychosis, new directions

Emerging Drugs

Volumn 4, Issue , 1999, Pages 127-151

  Goldstein, J M ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; OLANZAPINE; PROLACTIN; QUETIAPINE; RISPERIDAL; SEROTONIN 2 RECEPTOR; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERPROLACTINEMIA; LIMBIC SYSTEM; NIGRONEOSTRIATAL SYSTEM; PATIENT SATISFACTION; QUALITY OF LIFE; REVIEW; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

EID: 0032908180     PISSN: 13619195     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728214.4.1.127     Document Type: Review

References (101)